Related Experiment Video

Updated: Aug 16, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
09:48

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Published on: February 17, 2023

Obesity: Adipogenesis and Insulin Resistance

J K Sethi1

  • 1University of Cambridge, Department of Clinical Biochemistry, Addenbrooke's Hospital, Box 232, Hills Road, Cambridge, CB2 2QR. jks30@cam.ac.uk

Idrugs : the Investigational Drugs Journal
|August 2, 2005
PubMed

Insights

This meeting highlighted molecular mechanisms in adipogenesis and insulin resistance for drug discovery. New compounds targeting obesity and diabetes, including PPARgamma antagonists and insulin sensitizers, were discussed.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Metabolic Diseases

Background:

  • Adipogenesis and insulin resistance are key processes in metabolic diseases.
  • Understanding molecular mechanisms is crucial for developing effective treatments.
  • Obesity and diabetes represent significant global health challenges.

Purpose of the Study:

  • To review recent advancements in adipogenesis and insulin resistance research.
  • To identify potential drug discovery targets for obesity and diabetes.
  • To discuss novel compounds with therapeutic potential.

Main Methods:

  • Focus on molecular mechanisms relevant to drug discovery.
  • Presentation of new chemical entities and their properties.
  • Discussion of compounds in preclinical and clinical development.

Main Results:

  • Identified LIFR antagonist (hLIF05) as a potential therapeutic agent.
  • Characterized LG-100641, a selective PPARgamma antagonist with insulin-sensitizing effects.
  • Reviewed small molecule insulin sensitizers like CLX-0901, TLK-17411, and S-15261.

Conclusions:

  • Novel molecular targets and compounds show promise for treating obesity and diabetes.
  • Further research into these agents could lead to new therapeutic strategies.
  • The development of insulin sensitizers remains an active area of pharmaceutical research.

More Related Videos

Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro10:40

Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro

Published on: December 5, 2025

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...